11. Danish Conference on Biotechnology and Molecular Biology

Glycobiology and Carbohydrate Biotechnology

Date Thursday, May 26 - Friday, May 27, 2016
Location Hotel Munkebjerg, Vejle
Organizers Danish Biotechnological Society

Carbohydrates are essential for life of all living cells. With functional roles in biological processes and interactions they are of significant importance to human health and nutrition, and to symbiotic activity in the digestion system. Glycans play major roles for the pharmacokinetic properties of therapeutic glycoproteins. Recent pharmaceutical efforts are aimed at producing recombinant glycoproteins with simple and more homogeneous glycan structures in order to avoid immunogenicity and improve uptake and circulatory half-life. The present conference will focus on the latest developments in glycobiology and glycomics in relation to pharma, nutrition and analytical methods:


  • Glycan biosynthetic pathways
  • Glyco-engineering of production cell lines
  • Glycosylation of therapeutic proteins

Health and pharma

  • Immuno therapy
  • Cancer treatment
  • Allergy

Carbohydrates in relation to synbiotics and nutrition

  • Human milk oligosaccharides
  • Synbiotics: prebiotics and probiotics,
  • Microbial carbohydrate transporters and metabolomics

Analysis methods and technology

  • Glycoarray analyses
  • Mass spectrometry
  • Structure elucidation

Speakers confirmed

  • Birte Svensson, Enzyme and Protein Chemistry, DTU Systems Biology, DK
  • Carl H. June, University of Pennsylvania, USA
  • Hans Wandall, Glycomics Centre, KU, DK
  • Jørn Dalgaard Mikkelsen, DTU Biocehmical Engineering, DK
  • Lars Bode, USCD, USA
  • Nico Callewaert, University of Gent, Belgium
  • Niels Banke, Glycom, DK
  • Norbert Sprenger, Nestlé Research Center, Nestec Ltd, CH
  • Richard D. Cummings, Harvard Center for Glycoscience, Boston, USA
  • Susanne Brix Pedersen, DTU Systems Biology, DK
The conference includes a poster session as well as a commercial exhibition of equipment, consumables and services to Danish biotechnology.
The conference is organised in collaboration with Danish Society of Biochemistry and Molecular Biology.



Regular fee
Members of DBS or DSBMB: 3200 kr, Non-members : 3700 kr

Reduced fee for Ph.D. and M.Sc. students
Members of DBS or DSBMB: 1600 kr, Non-members 2100 kr

Deadline for poster abstracts and registration: May 2, 2016.

» Register here

» Poster Submission

Anne Dalgaard, IDA Netværkscenter, Kalvebod Brygge 31 - 33, DK-1780 Kbh V, Tel.: 33 18 46 34, Fax: 33 18 48 99, e-mail: ada@ida.dk.


Danish Biotechnological Society (DBS) is a scientific society established in 2006 in collaboration between Danish Biotechnology Forum and The Danish Society for Biochemistry and Molecular Biology. DBS is organised as part of The Danish Society of Engineers, IDA Biotechnology. The purpose of DBS is to facilitate networking within the field of biotechnology in Denmark, creating links between universities, research institutions, hospitals and companies. DBS represents professionals working with biotechnology and seeks to promote and communicate important issues on biotechnology, biochemistry and molecular biology to the public. DBS organises scientific conferences and meetings on biotechnology.

Working group members

  • Anders Vagnø Pedersen, Right Level Pharma Consult
  • Carola Heesemann, DTU / SBE
  • Cecilia Thomas, KU
  • Eric Paul Bennett, KU
  • Holti Kellezi, Novo Nordisk /Synapse
  • Jochen Förster, Novo Center for Biosustaninability, DTU
  • Lars Haastrup Pedersen, AaU
  • Leif Schauser, Qiagen Aarhus
  • Niklas Cvetanovski, COBIS
  • Nils Joakim Færgemann, SDU
  • Peter Kristensen AU
  • Søren Spanner, COBIS
  • Verena Volf, DTU / SBE.